News | October 08, 2021
Lincoln Pharma gets Australian TGA approval
The company plans to expand its portfolio in regulated markets aggressively
The company plans to expand its portfolio in regulated markets aggressively
The company's sustainability programme was evaluated on its policies, actions put in place to support objectives and targets, as well as results that were generated from the programme
Takeda to exclusively commercialize JR-141 outside the U.S. (except Japan and certain other Asia-Pacific countries) upon regulatory approval
The site's strategic location in the logistics hubs of the Auvergne Rhone-Alpes region is an advantage, along with the benefit of geographical proximity to Arrow's headquarters in Lyon
TCS to help Apoteket drive its digital transformation across sales channels and internal processes
In terms of volume, the company commands a market share 25 per cent globally for Gliclazide, as per the IQVIA report
Chericof 12, the first prescription cough syrup in India which gives relief for up to 12 hours, is manufactured using Polistirex technology for sustained release of the drug
The company operates in over eight cities and the start-up plans to expand its reach to over 100 non-metro cities in the next 18-24 months
It paves way for the launch of Selumetinib 10 mg & 25 mg capsule in India, subject to the receipt of related statutory approvals and licenses
Post normalisation of high growth months of April and May this year the average IPM growth from June to August this year stood at 15.2 % YoY : Ind-Ra reports
Subscribe To Our Newsletter & Stay Updated
